Landscapes / Targets

Bcl-2

15 drugs act on Bcl-2, in 69 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs15

DrugHow it worksCompanyStageNext dateDetails
—
Approved Nov 2026soonPhase 1/2 trial completes
BCL-2 inhibitor
AbbVie · Public ABBV
Approved Nov 2026soonPhase 2 trial completes
—
Approved in China Dec 2026Phase 2 trial completes
—
AbbVie · Public ABBV
Phase 3 31 Dec 2026Phase 1 trial completes
Mesutoclaxnot checked
—
Phase 3 Dec 2027Phase 2 trial completes
—
Phase 3 Dec 2030Phase 3 trial completes
—
Phase 2 1 Dec 2026soonPhase 2 trial completes
—
Phase 2 30 Mar 2028Phase 2 trial completes
—
AbbVie · Public ABBV
Phase 1/2 Dec 2030Phase 1/2 trial completes
—
Phase 1/2 —
—
Phase 1 Dec 2026Phase 1 trial completes
—
Phase 1 31 Dec 2026Phase 1 trial completes
—
Phase 1 Mar 2027Phase 1 trial completes
—
Phase 1 30 Jul 2027Phase 1 trial completes
—
Phase 1 7 Aug 2028Phase 1 trial completes

About this list

Checked
14 of 15 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Bcl-2

Following is part of Solo: you see every change to Bcl-2 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in